KRISTI STEINBACHER: Open Payments
NPI 1770936833 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110 in 6 payments from 5 companies in 2025. Trend: 2023 $146 · 2024 $38 · 2025 $110
Food & beverage: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
Products named: VRAYLAR, TRINTELLIX, Qelbree, CAPLYTA, REXULTI.
Industry payments across OR — which companies pay providers there.
